| Issue |
Title |
File |
| Vol 21, No 3 (2025) |
Results of using targeted methods in repeat prostate biopsy in patients with negative results of primary systemic biopsy |
(Rus)
|
|
Zhilov M.S., Yusufov A.G., Guspanov R.I., Kotov S.V.
|
| Vol 21, No 3 (2025) |
Prostate cancer Gleason score 6 (3 + 3): To operate or not to operate? |
(Rus)
|
|
Dzhalilov I.B., Rybalchenko V.A., Rumyantseva D.I., Shkarupa A.G., Shkarupa D.D., Konstantinova A.M., Mamizhev E.M., Kostin A.A., Semeniakin I.V., Gadzhiev N.K.
|
| Vol 21, No 3 (2025) |
Oncological outcomes of laparoscopic radical prostatectomy in patients with intermediate risk prostate cancer |
(Rus)
|
|
Petrov S.B., Arnautov A.V., Nikulina K.A., Yakovlev V.D., Reva S.A.
|
| Vol 21, No 2 (2025) |
Role of darolutamide in intensification of treatment of patients with hormone-sensitive prostate cancer: who needs the triplet combination? |
(Rus)
|
|
Volkova M.I., Turupaev K.A.
|
| Vol 21, No 2 (2025) |
Determining the frequency of discrepancies in ISUP values for prostate cancer after standard biopsy and radical prostatectomy: multicenter study |
(Rus)
|
|
Talyshinskii A.E., Govorov A.V., Kamyshanskaya I.G., Rubtsova N.A., Kryuchkova O.V., Zarya E.V., Pushkar D.Y.
|
| Vol 21, No 2 (2025) |
Biobanking prostate tissue |
(Rus)
|
|
Asfandiyarova I.V., Vlasova A.O., Velikomolova Y.B., Shchekin V.S., Urmantsev M.F., Pavlov V.N.
|
| Vol 21, No 2 (2025) |
HRR gene mutations and characteristics of the tumor microenvironment as predictors of response to olaparib therapy in metastatic castration-resistant prostate cancer |
(Rus)
|
|
Stukan A.I., Vtorushin S.V., Bogdan A.P., Semiglazova Т.Y., Tovbulatova K.R., Bodnya V.N., Porkhanov V.A., Dovlatbekyan A.A., Chagiev M.A., Khoreva D.V.
|
| Vol 21, No 1 (2025) |
Immediate results of perineal implantation of a prostate-rectum biodegradable spacer |
(Rus)
|
|
Novikov R.V., Karandashov V.K., Zhivulina T.V., Ponomareva O.I., Burovik I.A., Tyatkov S.A., Kulish A.V., Protoshchak V.V., Lyasovich G.A., Novikov S.N.
|
| Vol 21, No 1 (2025) |
Review of the article “Prostate cancer. Future of using quantitative magnetic resonance imaging” |
(Rus)
|
|
Golbits A.B.
|
| Vol 21, No 1 (2025) |
Viral microbiome of prostate tissue in benign prostatic hyperplasia and prostate cancer |
(Rus)
|
|
Kamalov A.A., Mikhaleva L.M., Karpov V.K., Okhobotov D.A., Takhirzade T.B., Pshikhachev A.M., Nesterova O.Y., Shaparov B.M., Strigunov A.A., Pechnikova V.V., Osmanov O.A.
|
| Vol 21, No 1 (2025) |
Prostate cancer. Future of using quantitative magnetic resonance imaging |
(Rus)
|
|
Abuladze L.R., Semenov D.S., Varyukhina M.D.
|
| Vol 21, No 1 (2025) |
Do men aged 75 years and older need prostate biopsy? |
(Rus)
|
|
Volkova M.I., Al-Akel I.S., Gridneva Y.V., Pokataev I.A., Sinitsina O.R., Parts S.A.
|
| Vol 20, No 4 (2024) |
Effect of the PI-RADS score on adverse surgical outcomes in patients with prostate cancer after radical prostatectomy |
(Rus)
|
|
Popov A.M., Anikanova E.V., Kryuchkova O.V., Sokolov A.A., Abdryakhimov E.F., Zarya E.V.
|
| Vol 20, No 4 (2024) |
Development of a deep learning-based system for aiding in the determination of Prostate Imaging Reporting and Data System (PI-RADS) scores: an international multicenter study |
(Rus)
|
|
He M., Enikeev M.E., Rzaev R.T., Chernenkiy I.M., Feldsherov M.V., Li H., Hu K., Shpot E.V., Rapoport L.M., Glybochko P.V.
|
| Vol 20, No 4 (2024) |
Anatomical aspects of vessel-sparing radiation therapy for prostate cancer |
(Rus)
|
|
Novikov R.V., Lyasovich G.A., Ponomareva O.I., Karandashov V.K., Burovik I.A., Tyatkov S.A., Kulish A.V., Protoshchak V.V., Novikov S.N.
|
| Vol 20, No 4 (2024) |
Prognostic significance of germline mutations in DNA homologous recombination repair genes in patients with primary metastatic prostate cancer |
(Rus)
|
|
Muradkhanau A.I., Sinyavskaya E.S., Rolevich A.I., Goncharova R.I., Evseev N.E., Zakharova V.A., Smal M.P., Parmon M.L., Semenov S.A., Krasny S.A., Polyakov S.L.
|
| Vol 20, No 4 (2024) |
Metastasis-directed therapy for metachronous metastases of prostate cancer |
(Rus)
|
|
Sarkisyan A.V., Bulychkin P.V., Khachaturyan A.V., Kufelkina A.A., Ladyko D.D.
|
| Vol 20, No 3 (2024) |
Androgen deprivation therapy and cardiological risks in patients with prostate cancer. Are all drugs the same? |
(Rus)
(Eng)
|
|
Alekseev B.Y., Perepukhov V.M., Nyushko K.M., Poltavskaya M.G.
|
| Vol 20, No 3 (2024) |
Estimation of 223Ra in a sewage system of hospital during radiopharmaceutical therapy with 223Ra dichloride (Xofigo®) |
(Rus)
|
|
Chipiga L.A., Petryakova A.V., Vodovatov A.V., Saprykin K.S., Vazhenina D.A., Stanzhevskiy A.A., Maystrenko D.N.
|
| Vol 20, No 3 (2024) |
Side effects and complications of high dose-rate brachytherapy: literature review and our own observations |
(Rus)
|
|
Shchukina E.O., Biryukov V.A., Karyakin O.B., Ivanov S.А.
|
| Vol 20, No 3 (2024) |
Results of treatment of patients 75 years or older with non-metastatic prostate cancer in real clinical practice |
(Rus)
|
|
Volkova M.I., Al-Akel I.S., Gridneva Y.V., Ryabinin R.I., Pokataev I.A.
|
| Vol 20, No 3 (2024) |
Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness |
(Rus)
|
|
Nyushko K.M., Perepukhov V.M., Alekseev B.Y., Apolikhin O.I., Kaprin A.D., Sivkov A.V., Koryakin A.V., Aleshin V.P.
|
| Vol 20, No 2 (2024) |
Clinical and economic impact of modern pharmaceuticals on reducing mortality from hormone-sensitive prostate cancer with high-volume disease |
(Rus)
|
|
Avxentyev N.A., Nyushko K.M., Makarova Y.V.
|
| Vol 20, No 2 (2024) |
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM) |
(Rus)
|
|
Alekseev B.Y., Anzhiganova Y.V., Sultanbaev A.V., Bystrov A.A., Orlov A.S., Gopp G.V., Kopyltsov A.V., Lykov A.V., Atduev V.A., Alekseeva G.N., Rodygin L.M., Varlamov S.A., Shestakov A.V., Maturov M.R., Urmantsev M.F., Lankina L.V., Parsadanova E.L., Startsev V.Y., Vedrova O.V., Andreev S.Y., Perevoshchikov A.A., Mailyan O.A., Kalpinskiy A.S.
|
| Vol 20, No 2 (2024) |
Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy |
(Rus)
|
|
Nikolaeva E.A., Krylov A.S., Ryzhkov A.D., Geliashvili T.M., Pavlova A.V., Goryainova A.Y., Murashko R.A.
|
| Vol 20, No 2 (2024) |
Salvage radiation therapy after radical prostatectomy: long-term results of a prospective study |
(Rus)
|
|
Bulychkin P.V., Matveev V.B., Tkachev S.I.
|
| Vol 20, No 2 (2024) |
Artificial intelligence in diagnosis of prostate cancer using magnetic resonance imaging. New approach |
(Rus)
|
|
Aboyan I.A., Redkin V.A., Nazaruk M.G., Polyakov A.S., Pakus S.M., Lemeshko S.I., Hasigov А.V.
|
| Vol 20, No 2 (2024) |
Comparison of the effectiveness of radiation and surgical treatment methods in high and very high risk prostate cancer |
(Rus)
|
|
Novikov S.N., Samartseva E.E., Novikov R.V., Nosov A.K., Protsenko S.A., Buevich N.N., Petrov S.B., Ilyin N.D., Merezhko Y.O., Antipov F.E., Kanaev S.V.
|
| Vol 20, No 1 (2024) |
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: a subgroup analysis of the randomised clinical TITAN study |
(Rus)
|
|
Merseburger A.S., Agarwal N., Bhaumik A., Lefresne F., Karsh L.I., Pereira de Santana Gomes A.J., Juárez Soto Á., Given R.W., Brookman-May S.D., Mundle S.D., McCarthy S.A., Uemura H., Chowdhury S., Chi K.N., Bjartell A.
|
| Vol 20, No 1 (2024) |
Optimization of a method for determination of docetaxel sensitivity using prostate cancer organoids |
(Rus)
|
|
Nikulin S.V., Silkina M.O., Razumovskaya A.V., Raygorodskaya M.P., Alekseev B.Y.
|
| Vol 20, No 1 (2024) |
Assessment of miR-21-5p, miR-451a, and miR-144-3p level in urine in differential diagnosis of localized prostate cancer |
(Rus)
|
|
Dolotkazin D.R., Averinskaya D.A., Knyazev E.N., Raigorodskaya M.P., Kolodeeva O.E., Kolodeeva O.E., Shkurnikov M.Y., Alekseev B.Y.
|
| Vol 20, No 1 (2024) |
Salvage lymph node dissection in nodal oligorecurrent prostate cancer: literature review and our experience |
(Rus)
|
|
Shirokorad V.I., Izmailov A.A., Lupashko D.G.
|
| Vol 20, No 1 (2024) |
Methodological aspects of implantation of a Russian prostate-rectum spacer based on stabilized hyaluronic acid of non-animal origin |
(Rus)
|
|
Novikov R.V., Zhivulina T.V., Sysoeva V.V., Protoshchak V.V., Karandashov V.K., Gozalishvili S.M., Novikov S.N.
|
| Vol 20, No 1 (2024) |
Long-term outcomes of hypofractionated radiation therapy in patients with high risk prostate cancer |
(Rus)
|
|
Bulychkin P.V., Ekaterinushkin D.A., Tkachev S.I., Khachaturyan A.V., Nayanov G.B., Ladyko D.D., Selezneva T.D.
|
| Vol 19, No 4 (2023) |
Evaluatoion of intraoperative histology during nerve-sparing radical prostatectomy |
(Rus)
|
|
Kotov S.V., Byadretdinov I.S., Guspanov R.I., Pulbere S.A., Yusufov A.G.
|
| Vol 19, No 4 (2023) |
Multiparametric magnetic resonance imaging in diagnosis of local prostate cancer recurrence after radiation therapy and radical prostatectomy: a unified PI-RR reporting system |
(Rus)
|
|
Rubtsova N.A., Alekseev B.Y., Kaprin A.D., Kryuchkova O.V., Talyshinskii A.E.
|
| Vol 19, No 4 (2023) |
Robot-assisted radical prostatectomy in patients after endoscopic surgeries on the prostate |
(Rus)
|
|
Guliev B.G., Ilyin D.M., Kharchenko P.V., Talyshinskiy A.E., Krylov O.A.
|
| Vol 19, No 4 (2023) |
Salvage high-dose rate brachytherapy for local recurrence of prostate cancer after radical prostatectomy |
(Rus)
|
|
Solodkiy V.A., Pavlov A.Y., Dzidzaria A.G., Tsibulskii A.D.
|
| Vol 19, No 3 (2023) |
Clinical use of high dose-rate brachytherapy in treatment of patients with localized prostate cancer and infravesical obstruction |
(Rus)
|
|
Yagudaev D.M., Martov A.G., Ergakov D.V., Yagudaev D.D., Kadyrov Z.A.
|
| Vol 19, No 3 (2023) |
Radical prostatectomy in the Russian Federation: features of perioperative management and nuances of technical execution |
(Rus)
|
|
Gadzhiev N.K., Rybalchenko V.A., Dzhalilov I.B., Shkarupa D.D., Shkarupa A.G., Semeniakin I.V., Petrov S.B.
|
| Vol 19, No 2 (2023) |
Clinical aspects of prostate cancer in patients with germinal and somatic mutations in DNA homologous recombination repair genes |
(Rus)
|
|
Stukan A.I., Murashko R.A., Nyushko K.M., Semiglazova T.Y., Grigoryan M.M., Zhdanov V.S., Tovbulatova H.R., Mukhortov A.A.
|
| Vol 19, No 2 (2023) |
Tissue expression of LC3B autophagy marker as a potential biomarker of prostate cancer recurrence after treatment with high-intensity focused ultrasound (pilot study) |
(Rus)
|
|
Voronina E.S., Fomkin R.N., Bucharskaya A.B., Palatova T.V., Maslyakova G.N., Fomkina O.A.
|
| Vol 19, No 2 (2023) |
Comparison of salvage high dose-rate brachytherapy and external beam radiotherapy for treatment of prostate cancer local recurrence after radical prostatectomy |
(Rus)
|
|
Pavlov A.Y., Dzidzaria A.G., Tsibulskiy A.D., Mirzakhanov R.I.
|
| Vol 19, No 2 (2023) |
Comparative analysis of 10-year functional outcomes of robot-assisted radical prostatectomy and radical retropubic prostatectomy. Experience of the Urology Clinic of the A.I. Evdokimov Moscow State University of Medicine and Dentistry |
(Rus)
|
|
Ramazanov K.K., Kolontarev K.B., Ter-Ovanesov M.D., Govorov A.V., Vasilyev A.O., Kazakov A.S., Pushkar D.Y.
|
| Vol 19, No 2 (2023) |
The first experience of using prostate cancer organoids as a model for personalized selection of drugs |
(Rus)
|
|
Nikulin S.V., Alekseev B.Y., Poloznikov A.A., Osipyants A.I.
|
| Vol 19, No 1 (2023) |
Classification urine leakage from urethrovesical anastomosis after prostatectomy |
(Rus)
|
|
Petrosyan G.S., Keln A.A.
|
| Vol 19, No 1 (2023) |
Prostate cancer: current situation in Russia and Saint Petersburg according to medical statistical indicators |
(Rus)
|
|
Popov S.V., Guseynov R.G., Khizha V.V., Yazenok A.V., Orlov I.N., Sivak K.V., Perepelitsa V.V., Bunenkov N.S., Ulitina A.S.
|
| Vol 19, No 1 (2023) |
Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer |
(Rus)
|
|
Makarova K.S., Gumenetskaya Y.V., Biryukov V.A., Rodina T.A., Galitsyna A.B., Shchukina E.O., Karyakin O.B., Ivanov S.A., Kaprin A.D.
|
| Vol 19, No 1 (2023) |
Androgen receptor signaling mechanism in prostate cancer: resistance to antiandrogen therapy and association with DNA repair genes |
(Rus)
|
|
Stukan A.I., Goryainova A.Y., Grigoryan M.M., Kutyan V.F., Zhdanov V.S., Semiglazova T.Y., Imyanitov E.N.
|
| Vol 19, No 1 (2023) |
Comparative analysis of 10-year oncological outcomes of robot-assisted radical prostatectomy and radical retropubic prostatectomy. Experience of the Urology Clinic of the A.I. Evdokimov Moscow State University of Medicine and Dentistry |
(Rus)
|
|
Ramazanov K.K., Kolontarev K.B., Ter-Ovanesov M.D., Govorov A.V., Vasilyev A.O., Kazakov A.S., Pushkar D.Y.
|
| Vol 18, No 3 (2022) |
Cardiovascular safety of hormone therapy for prostate cancer |
(Rus)
|
|
Andreev D.A., Zavyalov A.A.
|
| Vol 18, No 3 (2022) |
Nomograms for predicting local recurrence in prostate cancer patients with a positive resection margin |
(Rus)
|
|
Nyushko K.M., Perepukhov V.M., Alekseev B.Y.
|
| Vol 18, No 3 (2022) |
Prostate-specific antigen density as a predictor of recurrence-free survival following combined hormonal-radiation therapy of localized prostate cancer |
(Rus)
|
|
Kneev A.Y., Shkolnik M.I., Bogomolov O.A., Verdiev N.D., Zharinov G.M.
|
| Vol 18, No 4 (2022) |
Using Delphi method in the development of a modern prostate cancer care quality indicators |
(Rus)
|
|
Andreev D.A., Zavyalov A.A.
|
| Vol 18, No 4 (2022) |
Outcomes of radical prostatectomy in treatment of locally advanced prostate cancer: clinical observations |
(Rus)
|
|
Popov S.V., Guseynov R.G., Orlov I.N., Sivak K.V., Skryabin O.N., Perepelitsa V.V., Katunin A.S., Yasheva S.Y., Zaytsev A.S.
|
| Vol 18, No 4 (2022) |
Prospective study of prostate cancer detection using multiparametric magnetic resonance imaging ultrasound-guided fusion, standard, and saturation biopsy |
(Rus)
|
|
Petov V.S., Timofeeva E.Y., Bazarkin A.K., Morozov A.O., Taratkin M.S., Ganzha T.M., Danilov S.P., Chernov Y.N., Abdusalamov A.F., Amosov A.V., Enikeev D.V., Krupinov G.E.
|
| Vol 18, No 2 (2022) |
An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice |
(Rus)
|
|
Nyushko K.M., Alekseev B.Y., Perepukhov V.M., Shevchuk I.M., Atduev V.A., Zdobnikov А.B., Venskel V.B., Gurin Е.V., Eremenko A.V., Belov I.V., Gavrilova V.D., Ismakov R.M., Prokhorov D.G., Nikitin R.V., Usinin E.A., Kopyltsov E.I., Leonov O.V., Leonov А.O.
|
| Vol 18, No 2 (2022) |
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
|
Alekseev B.Y., Nyushko K.M., Gafanov R.A., Kirichek A.A., Anzhiganova Y.V., Kopyltsov E.I., Sundui Y.Y., Pashanov Е.D., Petyushin A.N., Matveev V.B.
|
| Vol 18, No 2 (2022) |
Utility of fusion biopsy for choosing prostate cancer patients eligible for focal therapy |
(Rus)
|
|
Romanov R.A., Koryakin A.V., Kirpatovskiy V.I., Alekseev B.Y.
|
| Vol 18, No 2 (2022) |
Pelvic lymphadenectomy for radical prostatectomy: perioperative and oncological results |
(Rus)
|
|
Popov S.V., Guseynov R.G., Orlov I.N., Skryabin O.N., Perepelitsa V.V., Katunin А.S., Mirzabekov M.M., Zaytsev A.S., Yasheva S.Y.
|
| Vol 18, No 2 (2022) |
Tissue expression of the antiapoptotic protein survinin as a potential biomarker of prostate cancer |
(Rus)
|
|
Aboyan I.A., Fedotova E.N., Lemeshko S.I., Maksimov A.Y., Komarova E.F.
|
| Vol 18, No 2 (2022) |
Bladder neck-sparing retropubic radical prostatectomy: assessing risk factors for detection of positive surgical margins |
(Rus)
|
|
Belousov I.I., Kogan M.I., Tokhtamishyan S.K., Chibichyan M.B.
|
| Vol 18, No 1 (2022) |
Apalutamide compared with darolutamide for the treatment of non-metastatic castration resistant prostate cancer: efficacy and tolerability in a matching-adjusted indirect comparison |
(Rus)
|
|
Chowdhury S., Oudard S., Uemura H., Joniau S., Dearden L., Capone C., van Sanden S., Diels J., Hadaschik B.A.
|
| Vol 18, No 1 (2022) |
Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer |
(Rus)
|
|
Avxentyev N.A., Derkach E.V., Makarova Y.V.
|
| Vol 18, No 1 (2022) |
Review of the article “Evaluation of the functional results and safety of early removal of the urethral catheter after laparoscopic radical prostatectomy” |
(Rus)
|
|
Atduev V.A.
|
| Vol 18, No 1 (2022) |
Clinical experience of using the radium-223 in patients with bone metastasis of castration-resistant prostate cancer |
(Rus)
|
|
Yurmazov Z.A., Usynin E.A., Medvedeva A.A., Polyakov A.A., Lushnikova N.A., Chernov V.I., Spirina L.V.
|
| Vol 18, No 1 (2022) |
High-dose-rate brachytherapy as monotherapy for prostate cancer: 5-year results |
(Rus)
|
|
Solodkiy V.A., Pavlov A.Y., Tsybulskii A.D., Dzidzaria A.G., Sorokin A.S., Mirzakhanov R.I.
|
| Vol 18, No 1 (2022) |
Evaluation of the functional results and safety of early removal of the urethral catheter after laparoscopic radical prostatectomy |
(Rus)
|
|
Kotov S.V., Guspanov R.I., Byadretdinov I.S., Ryabov M.A., Pulbere S.A., Yusufov A.G., Zhilov M.S.
|
| Vol 18, No 1 (2022) |
Efficacy of different types of radical prostatectomy in patients with localized prostate cancer |
(Rus)
|
|
Shamin M.V., Kyzlasov P.S., Pomeshkin E.V., Bezrukov E.A.
|
| Vol 17, No 4 (2021) |
Prostate cancer in disabled settings |
(Rus)
|
|
Alekseev B.Y., Tombal’ B., Kel’n A.A.
|
| Vol 17, No 4 (2021) |
Combinatorial radiation therapy for prostate cancer with seminal vesicle invasion |
(Rus)
|
|
Makarova K.S., Gumenetskaya Y.V., Biryukov V.A., Strikanova I.A., Kireeva T.A., Lepilina O.G., Karyakin O.B., Ivanov S.A., Kaprin A.D.
|
| Vol 17, No 4 (2021) |
The role of microRNAs in the development of radioresistance of prostate cancer cells (experimental study) |
(Rus)
|
|
Makhotkin M.A., Chebotarev D.A., Tyutyakina M.G., Mashkarina A.N., Tarasov V.A., Kogan M.I., Chernogubova E.A.
|
| Vol 17, No 4 (2021) |
Prognostic significance of PTEN, RB1 and BRCA2 gene loss in patients with localized and locally advanced prostate cancer |
(Rus)
|
|
Arnautov A.V., Musaelyan A.A., Nazarov V.D., Lapin S.V., Reva S.A., Petrov S.B., Orlov S.V.
|
| Vol 17, No 4 (2021) |
Nomograms for predicting the risk of biochemical recurrence in patients with prostate cancer after surgery |
(Rus)
|
|
Nyushko K.M., Perepukhov V.M., Gavrilova V.D., Alekseev B.Y.
|
| Vol 17, No 4 (2021) |
Analysis of miRNAs in the PSMA-positive fraction of plasma nano-sized extracellular vesicles in patients with prostate cancer |
(Rus)
|
|
Zabegina L.M., Nikiforova N.S., Nazarova I.V., Knyazeva M.S., Tsyrlina E.V., Reva S.A., Nosov A.K., Malek A.M.
|
| Vol 17, No 4 (2021) |
Review of the article “Nomograms for predicting the risk of biochemical recurrence in patients with prostate cancer after surgery” |
(Rus)
|
|
Petrov S.B.
|
| Vol 17, No 3 (2021) |
Current capabilities in treatment of non-metastatic castration-resistant prostate cancer: effectiveness, safety, and quality of life of patients taking darolutamide |
(Rus)
|
|
Alekseev B.Y., Perepukhov V.M., Nyushko K.M.
|
| Vol 17, No 3 (2021) |
Germinal BRCA-mutation significance in the tumor microenvironment formation Efficacy of PARP inhibition in late-line therapy of metastatic castration-resistant prostate cancer |
(Rus)
|
|
Stukan A.I., Goryainova A.Y., Riger N.A., Sharov S.V., Shatokhina A.S., Chukhray O.Y., Andreev D.V.
|
| Vol 17, No 3 (2021) |
Technologies to reduce radiation toxicity in prostate cancer patients: spacers - a simple and effective solution |
(Rus)
|
|
Novikov R.V., Novikov S.N.
|
| Vol 17, No 2 (2021) |
Low and high-dose-rate brachytherapy in combination with external beam radiotherapy for high risk prostate cancer |
(Rus)
|
|
Solodkiy V.A., Pavlov A.Y., Tsibulskii A.D., Panshin G.A., Dzidzaria A.G., Mirzahanov R.I.
|
| Vol 17, No 2 (2021) |
First experiment study in cytoreductive prostatectomy in patients with oligo-metastatic prostate cancer following neoadjuvant chemohormonotherapy |
(Rus)
|
|
Mager V.O., Orlov A.S., Gilmutdinov T.R., Veshkina A.A., Kovalenko D.A., Zamyatin A.V.
|
| Vol 17, No 2 (2021) |
Comparison of treatment results for patients with high-risk prostate cancer according to the EAU and NCCN criteria |
(Rus)
|
|
Reva S.A., Nosov A.K., Korol V.D., Arnautov A.V., Zyatchin I.V., Berkut M.V., Petrov S.B., Belyaev A.M.
|
| Vol 17, No 2 (2021) |
Review of the article “The first experience of transperineal prostate biopsy without antibiotic prophylaxis” |
(Rus)
|
|
Зырянов А.В.
|
| Vol 17, No 2 (2021) |
The first experience of transperineal prostate biopsy without antibiotic prophylaxis |
(Rus)
|
|
Chernysheva D.Y., Popov S.V., Orlov I.N., Tsoy A.V., Neradovskiy V.A.
|
| Vol 17, No 2 (2021) |
Reply to review of the article “First experiment study in cytoreductive prostatectomy in patients with oligo-metastatic prostate cancer following neoadjuvant chemohormonotherapy” |
(Rus)
|
|
авторов к.
|
| Vol 17, No 2 (2021) |
Review of the article “First experiment study in cytoreductive prostatectomy in patients with oligo-metastatic prostate cancer following neoadjuvant chemohormonotherapy” |
(Rus)
|
|
Широкорад В.А.
|
| Vol 17, No 2 (2021) |
Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists |
(Rus)
|
|
Matveev V.B., Alekseev B.Y., Kamolov B.S., Markova A.S.
|
| Vol 17, No 1 (2021) |
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer |
(Rus)
|
|
Mailyan O.A., Kalpinskiy A.S., Reshetov I.V., Nyushko K.M., Alekseev B.Y., Kokin S.P., Stakanov V.A., Golovashchenko M.P.
|
| Vol 17, No 1 (2021) |
PRIAPOS trial: new conception of pathogenesis of post-brahytherapy erectile dysfunction |
(Rus)
|
|
Novikov R.V., Ponomareva O.I., Novikov S.N.
|
| Vol 17, No 1 (2021) |
Prognostic factors for restoring orgasmic function in patients after radical prostatectomy |
(Rus)
|
|
Veliev R.A., Veliev E.I., Sokolov E.A.
|
| Vol 17, No 1 (2021) |
An original surgical method for the formation of fascial duplication in the elimination of damage to the anterior rectal wall during prostatectomy |
(Rus)
|
|
Yurgel Y.N., Alekseev B.Y., Kopyltsov E.I., Leonov O.V., Sikhvardt I.A., Leonova A.O., Vodolazskiy V.A., Durnev I.A., Yurgel N.Y.
|
| Vol 17, No 1 (2021) |
Comparing the efficacy of laparoscopic and open radical prostatectomy: analysis of treatment outcomes in patients with prostate cancer treated in three federal centers |
(Rus)
|
|
Nyushko K.M., Perepukhov V.P., Kozlova P.S., Chaykov V.S., Shchukina E.O., Dementyev I.O., Krasheninnikov A.A., Shevchuk I.M., Alekseev B.Y., Kaprin A.D., Ivanov S.A., Karyakin O.B.
|
| Vol 17, No 1 (2021) |
Review of the article “An original surgical method for the formation of fascial duplication in the elimination of damage to the anterior rectal wall during prostatectomy” |
(Rus)
|
|
Karnauh P.A.
|
| Vol 16, No 4 (2020) |
Dynamics of survival of patients with prostate cancer at the population level, taking into account the stage of the disease and place of residence |
(Rus)
|
|
Andreeva R.D., Nizamova R.S., Andreev A.A.
|
| Vol 16, No 4 (2020) |
Salvage high-dose-rate brachytherapy for recurrent prostate cancer |
(Rus)
|
|
Kaprin A.D., Ivanov S.A., Karyakin O.B., Obuhov A.A., Biryukov V.A., Borysheva N.B., Sanin D.B., Lepilina O.G., Smolkin A.L., Dem’yanovich A.V., Minaeva N.G., Mikhaylovskiy N.V.
|
| Vol 16, No 4 (2020) |
Review of the article “Computed tomography-guided pararectal prostate fusion biopsy” |
(Rus)
|
|
Zyryanov A.V.
|
| Vol 16, No 4 (2020) |
Efficacy and safety of radium-223 in routine clinical practice |
(Rus)
|
|
Matveev V.B., Markova A.S.
|
| Vol 16, No 4 (2020) |
Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors |
(Rus)
|
|
Alekseev B.Y., Krasheninnikov A.A., Nyushko K.M., Vorobyev N.V., Kaprin A.D.
|
| Vol 16, No 4 (2020) |
Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer |
(Rus)
|
|
Musaelyan A.A., Nazarov V.D., Lapin S.V., Pavlova O.N., Viktorov D.A., Toropovsky А.N., Boriskin A.G., Reva S.A., Petrov S.B.
|
| Vol 16, No 4 (2020) |
Computed tomography-guided pararectal prostate fusion biopsy |
(Rus)
|
|
Kopylov A.A., Gorelov V.P., Margaryants N.B., Gorelov S.I.
|
| 1 - 100 of 237 Items |
1 2 3 > >>
|
